Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging

被引:179
作者
Tung, CH [1 ]
Bredow, S [1 ]
Mahmood, U [1 ]
Weissleder, R [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Boston, MA 02129 USA
关键词
D O I
10.1021/bc990052h
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A variety of proteases are overexpressed or activated during pathogenesis and represent important targets for therapeutic drugs. We have previously shown that optical imaging probes sensitive in the near-infrared fluorescence (NIRF) spectrum can be used for in vivo imaging of enzyme activity. In the current study, me show that these probes can be designed with specificity for specific enzymes, for example, cathepsin D which is known to be overexpressed in many tumors. A NIR cyanine fluorochrome served as the optical reporter and was attached to the amino terminal of an 11 amino acid peptide sequence with specificity for cathepsin D. The peptides were subsequently attached to a synthetic graft copolymer for efficient tumoral delivery. The close spatial proximity of the multiple fluorochromes resulted in quenching of fluorescence in the bound state. A 350-fold signal amplification was observed post cleavage during in vitro testing. Cell culture experiments using a rodent tumor cell line stably transfected with human cathepsin D confirmed enzyme specific activation within cells. This sequence but not a scrambled control sequence showed enzyme specificity in vitro. We conclude that activatable NIRF optical probes can be synthesized to potentially probe for specific enzymes in living organisms.
引用
收藏
页码:892 / 896
页数:5
相关论文
共 17 条
  • [1] A long-circulating co-polymer in ''passive targeting'' to solid tumors
    Bogdanov, A
    Wright, SC
    Marecos, EM
    Bogdanova, A
    Martin, C
    Petherick, P
    Weissleder, R
    [J]. JOURNAL OF DRUG TARGETING, 1997, 4 (05) : 321 - &
  • [2] LONG-CIRCULATING BLOOD-POOL IMAGING AGENTS
    BOGDANOV, A
    WEISSLEDER, R
    BRADY, TJ
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) : 335 - 348
  • [3] An adduct of cis-diamminedichloroplatinum (II) and poly(ethylene glycol)poly(L-lysine)-succinate: Synthesis and cytotoxic properties
    Bogdanov, AA
    Martin, C
    Bogdanova, AV
    Brady, TJ
    Weissleder, R
    [J]. BIOCONJUGATE CHEMISTRY, 1996, 7 (01) : 144 - 149
  • [4] Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging
    Callahan, RJ
    Bogdanov, A
    Fischman, AJ
    Brady, TJ
    Weissleder, R
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 171 (01) : 137 - 143
  • [5] Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer
    Escot, C
    Zhao, Y
    Puech, C
    Rochefort, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (02) : 217 - 226
  • [6] GARCIA M, 1990, ONCOGENE, V5, P1809
  • [7] Design of sensitive fluorogenic substrates for human cathepsin D
    Gulnik, SV
    Suvorov, LI
    Majer, P
    Collins, J
    Kane, BP
    Johnson, DG
    Erickson, JW
    [J]. FEBS LETTERS, 1997, 413 (02) : 379 - 384
  • [8] HANCOCK WS, 1976, ANAL BIOCHEM, V71, P260, DOI 10.1016/0003-2697(76)90034-8
  • [9] Tumor progression and angiogenesis: Cathepsin B & Co.
    Keppler, D
    Sameni, M
    Moin, K
    Mikkelsen, T
    Diglio, CA
    Sloane, BF
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 1996, 74 (06) : 799 - 810
  • [10] LETO G, 1992, ANTICANCER RES, V12, P235